Sectors:
Min Investment:
Max Investment:
Target Investment:
(1996 - 2007)
Total Funding: $150M
Total Funding: $56M
Total Funding: $30M
Total Funding: $120M
Total Funding: $76M
Total Funding: $470M
Total Funding: $59M
Total Funding: $6M
2020
Founded Catalio in 2020, a multi-strategy investment firm, investing in breakthrough life sciences companies around the globe, founded by the world's leading scientist-entrepreneurs. www.cataliocapital.com
2020
2020
HealthCor Catalio Acquisition Corp. (NASDAQ: HCAQ), a special purpose acquisition company formed by HealthCor Management, L.P., which manages approximately $2.7 billion in assets across long/short and long only healthcare funds, and Catalio Capital Management, LP, a private equity firm that invests in breakthrough biomedical technology companies. www.hcspac.com
2015 - 2020
2015 - 2020
Camden Nexus was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by our Venture Partners, an elite group of world-renowned, serial scientist-entrepreneurs. To learn more: https://www.camdenpartners.com/nexus/about
2012 - 2013
2012 - 2013
A managed-futures hedge fund, focusing on asset allocation research & strategy.
2011 - 2011
2011 - 2011
Constellation Energy Group (former NYSE: CEG), was the only Baltimore-based Fortune 500 company. CEG was an energy producer, trader, and distributor that operated over 35 power plants and was one of the top electricity producers in the US. In 2012, it was acquired by (NYSE: EXC) for $7.9 billion.